Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing missense variant pathogenicity prediction with protein language models using VariPred.

Scientific reports·2024
Same author

Do antibody CDR loops change conformation upon binding?

mAbs·2024
Same author

abYpap: improvements to the prediction of antibody VH/VL packing using gradient boosted regression.

Protein engineering, design & selection : PEDS·2023
Same author

Antibody markup language (AbML) - a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw).

mAbs·2022
Same author

GraphQL for the delivery of bioinformatics web APIs and application to ZincBind.

Bioinformatics advances·2022
Same author

Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics.

mAbs·2022
Same journal

Discovery and optimization of a pH-responsive ultra-long-acting VHH-based growth hormone mimetic.

mAbs·2026
Same journal

Efficient inference of non-polyreactive antibody variants dependent on local fine-tuning.

mAbs·2026
Same journal

Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-Brainshuttle<sup>TM</sup> variants.

mAbs·2026
Same journal

Development of single-chain C1q affinity chromatography-mass spectrometry for the glycoform-resolved characterization of low-affinity immunoglobulin G interactions.

mAbs·2026
Same journal

Biparatopic targeting of IL-23 enables dual-epitope engagement and enhanced neutralization potency.

mAbs·2026
Same journal

Comparison of knockdown approaches for the generation of stable cell populations expressing afucosylated antibodies.

mAbs·2026
See all related articles

Related Experiment Video

Updated: May 24, 2025

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.8K

An antibody developability triaging pipeline exploiting protein language models.

James Sweet-Jones1, Andrew C R Martin1

  • 1Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, UK.

Mabs
|March 5, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a machine learning pipeline to identify therapeutic monoclonal antibodies (mAbs) with favorable developability features. The approach uses protein language models to select promising antibody candidates early in development, reducing costs and improving success rates.

Keywords:
Antibodiesdevelopabilitymachine learningpredictionprotein language models

More Related Videos

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.5K
Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins
08:46

Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins

Published on: September 22, 2020

3.7K

Related Experiment Videos

Last Updated: May 24, 2025

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.8K
Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.5K
Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins
08:46

Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins

Published on: September 22, 2020

3.7K

Area of Science:

  • Biotechnology
  • Immunology
  • Computational Biology

Background:

  • Therapeutic monoclonal antibodies (mAbs) are a key class of biologic drugs.
  • While binding affinity is crucial, antibody sequence and structure significantly impact developability and clinical success.
  • Late-stage failures due to poor developability are common and costly.

Purpose of the Study:

  • To develop a computational pipeline for selecting developable antibody candidates from large libraries.
  • To leverage machine learning and protein language models for early-stage antibody screening.
  • To reduce the cost and improve the efficiency of therapeutic antibody development.

Main Methods:

  • Utilized paired human antibody sequence data.
  • Developed a machine learning pipeline employing protein language models.
  • Clustered antibody sequences based on similarity to antibodies with known clinical success.

Main Results:

  • Identified a method to predict antibody developability based on sequence features.
  • The pipeline successfully identifies antibodies likely to possess favorable developability characteristics.
  • Demonstrated a strategy to triage out antibodies with poor developability potential early.

Conclusions:

  • The proposed pipeline is a valuable tool for selecting therapeutic monoclonal antibody candidates.
  • This approach can significantly reduce the cost and time associated with antibody discovery.
  • Facilitates the pursuit of novel therapeutics by improving early-stage candidate selection.